Kyle Gano

Insider Reports History

Entity
Individual
Location
Neurocrine Biosciences, Inc., 12780 El Camino Real, San Diego, CA
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyle Gano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NEUROCRINE BIOSCIENCES INC Chief Business Development Off Common Stock 135K $18M $132.89 Feb 13, 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Business Development Off Restricted Stock Unit 8.97K $1.19M $133.03 Feb 13, 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Business Development Off Stock Option 45.1K Feb 13, 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Business Development Off Incentive Stock Option 0 $81.49 Jan 2, 2024 Direct
NEUROCRINE BIOSCIENCES INC Chief Business Development Off Non-Qualified Stock Option 0 $79.02 Jan 2, 2024 Direct

Insider Reports Filed by Kyle Gano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NBIX NEUROCRINE BIOSCIENCES INC Feb 13, 2024 3 -$180K 4 Feb 15, 2024 Chief Business Development Off
NBIX NEUROCRINE BIOSCIENCES INC Feb 6, 2024 2 -$359K 4 Feb 8, 2024 Chief Business Development Off
NBIX NEUROCRINE BIOSCIENCES INC Jan 31, 2024 1 -$217K 4 Feb 2, 2024 Chief Business Development Off
NBIX NEUROCRINE BIOSCIENCES INC Jan 2, 2024 6 -$9.86M 4 Jan 4, 2024 Chief Business Development Off
NBIX NEUROCRINE BIOSCIENCES INC Aug 21, 2023 1 -$229K 4 Aug 23, 2023 Chief Business Development Off
NBIX NEUROCRINE BIOSCIENCES INC Feb 13, 2023 2 $0 4 Feb 15, 2023 Chief Business Development Off
NBIX NEUROCRINE BIOSCIENCES INC Feb 6, 2023 4 -$1.75M 4 Feb 8, 2023 Chief Business Development Off
NBIX NEUROCRINE BIOSCIENCES INC Jan 31, 2023 1 -$169K 4 Feb 2, 2023 Chief Business Development Off
NBIX NEUROCRINE BIOSCIENCES INC Feb 7, 2022 5 -$555K 4 Feb 9, 2022 Chief Business Development Off
NBIX NEUROCRINE BIOSCIENCES INC Jan 31, 2022 2 $0 4 Feb 2, 2022 Chief Business Development Off
NBIX NEUROCRINE BIOSCIENCES INC Jan 5, 2022 3 -$2.42M 4 Jan 7, 2022 Chief Business Development Off